Education
About Us
Working with TipRanks
Follow Us
Harbor BioSciences Inc (HRBR)
OTHER OTC:HRBR
Total Valuation
Harbor BioSciences has a market cap or net worth of $23.37M. The enterprise value is ―.
Market Cap$23.37M
Enterprise Value―
Share Statistics
Harbor BioSciences has 58,429,836 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,429,836
Owned by Insiders―
Owned by Institutions0.03%
Financial Efficiency
Harbor BioSciences’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -14.34%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-14.34%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee197.62K
Profits Per Employee-15.86K
Employee Count1,008
Asset Turnover0.84
Inventory Turnover44.64
Valuation Ratios
The current PE Ratio of Harbor BioSciences is -5.62. Harbor BioSciences’s PEG ratio is 0.04.
PE Ratio-5.62
PS Ratio0.00
PB Ratio0.51
Price to Fair Value0.51
Price to FCF-5.44
Price to Operating Cash Flow-7.47
PEG Ratio0.04
Income Statement
In the last 12 months, Harbor BioSciences had revenue of 199.21M and earned -15.98M in profits. Earnings per share was -0.39.
Revenue199.21M
Gross Profit-15.53M
Operating Income-36.87M
Pretax Income-19.35M
Net Income-15.98M
EBITDA10.39M
Earnings Per Share (EPS)-0.39
Cash Flow
In the last 12 months, operating cash flow was -5.89M and capital expenditures -4.23M, giving a free cash flow of -10.12M billion.
Operating Cash Flow-5.89M
Free Cash Flow-10.12M
Free Cash Flow per Share-0.17
Dividends & Yields
Harbor BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta18.85
52-Week Price Change-77.90%
50-Day Moving Average0.52
200-Day Moving Average0.84
Relative Strength Index (RSI)39.76
Average Volume (3m)1.58K
Important Dates
Harbor BioSciences upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Harbor BioSciences as a current ratio of 4.40, with Debt / Equity ratio of 4.13%
Current Ratio4.40
Quick Ratio4.24
Debt to Market Cap0.05
Net Debt to EBITDA-0.82
Interest Coverage Ratio-2.46K
Taxes
In the past 12 months, Harbor BioSciences has paid -3.37M in taxes.
Income Tax-3.37M
Effective Tax Rate0.17
Enterprise Valuation
Harbor BioSciences EV to EBITDA ratio is 7.82, with an EV/FCF ratio of -4.92.
EV to Sales0.41
EV to EBITDA7.82
EV to Free Cash Flow-4.92
EV to Operating Cash Flow-6.76
Balance Sheet
Harbor BioSciences has $110.06M in cash and marketable securities with $85.92M in debt, giving a net cash position of -$103.22M billion.
Cash & Marketable Securities$110.06M
Total Debt$85.92M
Net Cash-$103.22M
Net Cash Per Share-$1.77
Tangible Book Value Per Share$3.89
Margins
Gross margin is 35.74%, with operating margin of -18.51%, and net profit margin of -8.02%.
Gross Margin35.74%
Operating Margin-18.51%
Pretax Margin-9.71%
Net Profit Margin-8.02%
EBITDA Margin5.22%
EBIT Margin-9.71%
Analyst Forecast
The average price target for Harbor BioSciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―